Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CN102264227) C5ar antagonists

Office : China
Application Number: 200980152068.9 Application Date: 21.12.2009
Publication Number: 102264227 Publication Date: 30.11.2011
Grant Number: 102264227 Grant Date: 23.07.2014
Publication Kind : B
Prior PCT appl.: Application Number:PCTUS2009068941 ; Publication Number:2010075257 Click to see the data
IPC:
C07D 227/02
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
227
Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/-C07D225/184
02
with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
CPC:
A61K 31/445
A61K 31/451
A61K 31/454
A61K 31/4545
A61K 31/5377
C07D 211/60
C07D 401/06
C07D 401/10
C07D 401/12
C07D 401/14
C07D 405/10
C07D 413/12
C07D 413/14
C07D 211/14
C07D 211/22
Applicants: 凯莫森特里克斯股份有限公司
Inventors: 樊平臣
凯文·洛伊德·格林曼
曼莫汉·雷迪·莱莱蒂
李延东
贾伊·鲍尔斯
田中裕子
杨菊
曾一斌
Agents: 北京集佳知识产权代理有限公司 11227
北京集佳知识产权代理有限公司 11227
Priority Data: 61/139,919 22.12.2008 US
Title: (EN) C5ar antagonists
(ZH) C5aR拮抗剂
Abstract: front page image
(EN) Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
(ZH)

本发明提供了作为C5a受体调节剂的化合物。所述化合物是取代的哌啶,可用在用于治疗涉及C5a受体之病理性活化之疾病和病症的药物组合物和方法中。


Also published as:
DZDZP2011000468RSP-2016/0606UAa201109018AR077162IL213676MXMX/a/2011/006550
SG172338MA32975JP2012513402CA2747522EA201101009MX2011006550
CO6400172KR1020110100661BRPI0923384EP3078658NZ594140DK2381778
AU2009330194CA2965223VN28786ID051.4755TH128002IN3071/KOLNP/2011
PT2381778WO/2010/075257